Apollomics (APLM) Accumulated Expenses (2022 - 2025)
Apollomics (APLM) posted quarterly Accumulated Expenses of $6.1 million for Q4 2025, down 14.64% year-on-year from $7.2 million in Q4 2024, and down 40.43% on a QoQ basis from $10.3 million in Q2 2025.
Apollomics (APLM) Accumulated Expenses (2022 - 2025) Analysis & Trends
Apollomics (APLM) has reported Accumulated Expenses for 4 consecutive years, with $6.1 million the latest figure, recorded in Q4 2025.
- Quarterly Accumulated Expenses fell 14.64% year-over-year to $6.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.1 million (down 14.64% YoY) and the FY2025 annual result came in at $6.1 million, down 14.64% from the prior year.
- Accumulated Expenses declined to $6.1 million in Q4 2025 per APLM's latest filing, from $10.3 million in the prior quarter.
- Over the last five years, Accumulated Expenses for APLM reached as high as $12.8 million in Q2 2023 and fell as low as $6.1 million in Q4 2025.
- A 4-year average of $9.4 million and a median of $9.2 million in 2023 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Accumulated Expenses tumbled 30.67% — and 2025, when it increased 15.68%.
- Year by year, Accumulated Expenses stood at $11.7 million in 2022, then slipped by 21.52% to $9.2 million in 2023, then slipped by 21.79% to $7.2 million in 2024, then retreated by 14.64% to $6.1 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $6.1 million, $10.3 million, and $7.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.12 Mn |
| Jun 30, 2025 | 10.27 Mn |
| Dec 31, 2024 | 7.17 Mn |
| Jun 30, 2024 | 8.88 Mn |
| Dec 31, 2023 | 9.16 Mn |
| Jun 30, 2023 | 12.80 Mn |
| Dec 31, 2022 | 11.68 Mn |